Myomo (NYSE:MYO) shares took a hit today on fourth-quarter results that came up short of the consensus forecast. Shares of MYO fell 10% to $3.16 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 0.5%. The Boston-based wearable exoskeleton maker posted […]
Prosthetics
Wandercraft wins FDA clearance for exoskeleton for people with spinal cord injuries
Wandercraft announced today that it received FDA clearance for its Atalante X exoskeleton for individuals with spinal cord injuries (SCIs). The FDA granted clearance for people with SCIs at levels T5 to L5 to utilize the self-balancing robotic exoskeleton technology. The system enables those with limited mobility to stand up and walk again. Wandercraft says […]
ReWalk Robotics looks to the future following Lifeward rebrand
On Jan. 29, ReWalk Robotics announced a rebrand to “Lifeward.” The rebrand had, in many ways, been in the works for about six months. Really, though, Lifeward CEO Larry Jasinski started formulating this plan a few years ago. All it needed was a few key ingredients to propel the physical rehabilitation and recovery company forward. […]
ReWalk Robotics rebrands to ‘Lifeward’ as portfolio expands
ReWalk Robotics (Nasdaq:RWLK) today unveiled new corporate branding to officially begin operating as “Lifeward.” Beginning today, the company operates as Lifeward. Starting tomorrow, Jan. 30, 2024, its shares begin trading under the “LFWD” ticker on the Nasdaq market. Lifeward aims to deliver solutions for rehabilitation, recovery and more in the face of physical limitation or […]
Myomo to raise $6M with eyes on Medicare coverage
Myomo (NYSE:MYO) announced today that it entered into securities purchase agreements worth approximately $6 million. The company entered into agreements with certain new and existing institutional investors, plus insiders at Myomo. This agreement includes nearly 1.6 million shares of common stock priced at $3.80 per share. In conjunction with the offering, Myomo disclosed that it […]
Ekso Bionics earns Medicare win for exoskeleton tech
Ekso Bionics (Nasdaq:EKSO) announced that the Centers for Medicare & Medicaid Services (CMS) proposed a payment level for its exoskeleton. The Pricing, Data Analysis, and Coding (PDAC) contractor completed its review of the Ekso Indego Personal, approving the use of Healthcare Common Procedure Coding System (HCPCS) Code K1007 to bill Medicare for the device. CMS […]
ReWalk Robotics demonstrates proof-of-concept with next-gen, AI-powered exoskeleton
ReWalk Robotics (Nasdaq:RWLK) announced today that it successfully demonstrated proof-of-concept with its next-generation exoskeleton. The Israel-based company, which operates out of Marlborough, Massachusetts, in the U.S., incorporated AI into its latest technology. It integrated advanced sensing technologies and AI to enable autonomous decision-making in the new exoskeleton prototype. ReWalk hit this milestone as part of […]
Myomo closes $4.4M public offering
Myomo (NYSE:MYO) announced today that it closed its previously announced offering worth proceeds of approximately $4.4 million. The Boston-based wearable medical robotics maker priced its “reasonable best efforts” public offering last week. It included more than 7.3 million shares of common stock priced at 60¢ per share. Members of management, affiliated investors and certain high-quality, […]
Myomo prices $4.4M offering, scores reimbursement win
Myomo (NYSE:MYO) announced today that it priced a “reasonable best efforts” public offering worth proceeds of approximately $4.4 million. Boston-based Myomo’s offering includes more than 7.3 million shares of common stock priced at 60¢ per share. The company expects to close the offering on or about Aug. 29, 2023, subject to customary conditions. Myomo develops […]
ReWalk stock dips on Q2 EPS miss
ReWalk Robotics (Nasdaq:RWLK) shares fell today on second-quarter results that came in mixed compared to the consensus forecast. Shares of RWLK dipped 1.8% at 71¢ apiece in mid-afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — remained even. The Yokneam Illit, Israel-based company posted losses […]
ReWalk Robotics to acquire anti-gravity tech provider AlterG for $19M
ReWalk Robotics (Nasdaq:RWLK) announced that it executed an agreement to acquire AlterG, an anti-gravity system provider. The deal includes a purchase price of approximately $19 million at closing. ReWalk expects to close the deal on Aug. 11, with closing contingent upon the satisfaction of customary closing conditions. Additional cash earnouts may be paid based upon […]